Talubo, N.D.D.; Dela Cruz, E.W.B.; Fowler, P.M.P.T.; Tsai, P.-W.; Tayo, L.L.
QSAR-Based Drug Repurposing and RNA-Seq Metabolic Networks Highlight Treatment Opportunities for Hepatocellular Carcinoma Through Pyrimidine Starvation. Cancers 2025, 17, 903.
https://doi.org/10.3390/cancers17050903
AMA Style
Talubo NDD, Dela Cruz EWB, Fowler PMPT, Tsai P-W, Tayo LL.
QSAR-Based Drug Repurposing and RNA-Seq Metabolic Networks Highlight Treatment Opportunities for Hepatocellular Carcinoma Through Pyrimidine Starvation. Cancers. 2025; 17(5):903.
https://doi.org/10.3390/cancers17050903
Chicago/Turabian Style
Talubo, Nicholas Dale D., Emery Wayne B. Dela Cruz, Peter Matthew Paul T. Fowler, Po-Wei Tsai, and Lemmuel L. Tayo.
2025. "QSAR-Based Drug Repurposing and RNA-Seq Metabolic Networks Highlight Treatment Opportunities for Hepatocellular Carcinoma Through Pyrimidine Starvation" Cancers 17, no. 5: 903.
https://doi.org/10.3390/cancers17050903
APA Style
Talubo, N. D. D., Dela Cruz, E. W. B., Fowler, P. M. P. T., Tsai, P.-W., & Tayo, L. L.
(2025). QSAR-Based Drug Repurposing and RNA-Seq Metabolic Networks Highlight Treatment Opportunities for Hepatocellular Carcinoma Through Pyrimidine Starvation. Cancers, 17(5), 903.
https://doi.org/10.3390/cancers17050903